Wireless phone may increase risk of gliomas
the ONA take:
The continual use of a mobile phone increases the odds of developing glioma, an often-fatal brain cancer, according to Swedish researchers. Lead researcher Dr. Lennart Hardell stated that the risk of brain cancer is three times higher after 25 years or more of mobile phone use.
According to the study data, those using a mobile device for less than a year are half as likely to develop glioma when compared to those who reported using a wireless phone for 20 years or more. The effect of mobile use on the likelihood of developing other brain cancers was not examined.
These results contrasted with an earlier study released in 2010, that found no strong evidence of a link between continual mobile device use and increased changes of brain cancer development. The earlier study, financially supported in part by phone companies, is the largest study done on the topic.
The recent study suffers from similar limitations to other case control studies, in that the participants may not always remember their behaviors over a long span of time, which could impact the data. A study conducted in U.S. that examined cell phase use in Californians did however find that the rate of malignant tumors in the area of the brain nearest to where most people hold their phone increased considerably, even as incidence of brain gliomas lowered.
Additional study is warranted.
Risk of brain cancer is three times higher after 25 years or more of mobile phone use.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|